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The purpose of this study was to determine whether cell lysis by cytotoxic
lymphocytes may be affected by the presence of homologous restriction factor
(HRF)' on the surface of the target cells. HRF is a membrane protein that
inhibits the transmembrane channel-forming function of C8 and C9 of comple-
ment (1, 2). It inhibits homologous C8 and C9, but not their analogs of other
species. The cytolytic protein of human large granular lymphocytes (LGL) (3-5)
and human cytotoxic T lymphocytes (6) was shown to be immunochemically
related to C9. This C9-related protein (C9RP) was found also to crossreact with
C6, C7 (7), and C8 (4, 7). Because of certain structural and functional similarities
between C9RP and C9 (4, 8), the possibility arose that HRF might affect the
function of killer lymphocytes using C9RP. To explore this question, the anti-
body-dependent cellular cytotoxicity (ADCC) reaction was chosen using human
LGL as effectors and erythrocytes (E) as targets. E were selected as targets
because these cells are known to be lysed in the ADCC reaction by simple channel
insertion into their membrane (9), whereas killing of nucleated cells by lympho-
cytes is thought to involve additional factors (10, 11). HRF isolated from human
E (EH) was found to bind readily to sheep E (Es) and to retain its activity. Also,
the abnormal E of paroxysmal nocturnal hemoglobinuria (PNH) were used as
target cells since these are deficient in HRF and capable of being reconstituted
with isolated HRF (12). In the following, evidence will be reported suggesting
that HRF can inhibit target cell lysis by LGL.
Materials and Methods
Isolation of HRF.
￿
HRF derived from E membranes was purified using a rabbit anti-
HRF Sepharose column (12). ^100 mg of EH membrane protein was dissolved in 2%
deoxycholate (DOC), 50 mM NaCl, 2 mM PMSF, 1 mM benzamidine, 2 mM EDTA, 2
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mM EGTA, 20mM Tris-HCI, pH 8.4, at 4°C overnight in a total volume of 100 ml . The
material was centrifuged at 12,000 g to remove undissolved matter, and the supernatant
was dialyzed against 0.02% DOC, 50 mM NaCl, 20 mM Tris-HCI, pH 8.4 (starting buffer) .
The dissolved protein was passed first over a column containing rabbit IgG bound to
Sepharose to remove IgG-binding proteins and then over a Sepharose column containing
300 mg of bound anti-HRF Ig . The column was washed with starting buffer and then
with 0.1 M NaCl and 0.2M NaCl in starting buffer . HRF was eluted with 2 M NaCl and
then 2 M KBr in starting buffer . The yield was about 100 ag ofpurified protein . HRF in
0.02% DOC was radiolabeled with 1251 using the iodogen method (Pierce Chemical Co .,
Rockford, IL) .
Isolation ofC9RP.
￿
C9RP was isolated from human LGL by affinity chromatography
using a rabbit anti-C9RP-Sepharose immunoadsorbent column (4, 6) .
Preparation ofAbnormalPNH-E .
￿
The abnormal E of a PNH patient were enriched by
lysing the normal E with anti-DAF (decay accelerating factor) and guinea pig serum . 2 X
10 9 E were incubated with 500 Pl of rabbit anti-DAF for 30 min at 37°C, washed twice,
and then incubated with 1 ml of fresh guinea pig serum for 10 min at 37 °C . The cells
that remained after this treatment were washed thoroughly and used as PNH-E .
LGL . Peripheral blood mononuclear cells were isolated from heparinized normal
human blood by Ficoll-Isopaque gradient centrifugation using lymphocyte separation
medium (Litton Bionetics, Irving, TX) . Monocytes were removed by adherence to plastic .
The cell culture was stimulated with 0 .2% (vol/vol) phytohemagglutinin, M form (Gibco,
Grand Island, NY) and grown in the presence of 5 U/ml of human recombinant IL-2
(Amgen, Thousand Oaks, CA) for several weeks (4) .
Incorporation of "'I-HRF.
￿
Es or EH (3-5 X 10') were incubated with varying amounts
of 1251-HRF in a total volume of 1 ml for 2 h at 37 °C in a final concentration of 0 .004%
DOC . The cells were washed twice and the amount of HRF bound was determined by
quantitation of radioactivity . Es or EH not receiving HRF (negative controls) were also
treated with 0.004% DOC .
Incorporation of '257-DAF.
￿
5 X 10' EsA (antibody-coated Es) were incubated with
varying amounts of 1251-labeled, isolated DAF (13, 14) in a total volume of 3 ml for 2 h
at 37°C in a final concentration of 0.0013% DOC and 0.0013% NP-40 (Sigma Chemical
Co ., St . Louis, MO) . The cells were washed twice and the amount of DAF incorporated
was determined by quantitation of cell-associated radioactivity . Controls not receiving
DAF were treated with the same amount of detergent for the same length of time . The
preparation of DAF used was active, as indicated by accelerated dissociation of '251-Bb
from zymosan-C3b,Bb complexes (14) .
Reactive Lysis.
￿
10 7 Es with or without bound HRF were incubated at 37 °C with -3 jug
C5b6, 2 Ag C7, 2 Pg C8, and 15 ug C9 in a total volume of-50 Al . After 2 h, hemoglobin
release was measured at 412 nm .
Sensitization ofE with IgG Antibody.
￿
Es were coated with antibody (A) using the IgG
fraction of rabbit anti-E s (Cooper Biomedical, Malvern, PA) according to the package
instructions . EHA were made using the IgG fraction of anti-EH (Cooper Biomedical) . Es
or EH at 5 X 108 cells/ml were incubated with a 1 :8,000 dilution of antibody in the
presence of 10mM EDTA for 30 min at 37°C and washed three times .
ADCC .
￿
10' EsA or PNH-EA with or without bound HRF were incubated with 1-2 X
10' human LGL for 4 h at 37 °C . Lysis was determined spectrophotometrically at 412
nm .
Results
65 kD HRF, Incorporation into Es , and Inhibition of Reactive Lysis.
￿
HRF was
isolated from DOC-solubilized EH membranes by affinity chromatography using
rabbit anti-human HRF coupled to Sepharose 4 B . The column was washed
successively with 0.1 M and then 0.2 M NaCl in 0.02% DOC and eluted with 2
M NaCl in 0.02% DOC . Throughout the isolation procedure the pH wasmaintained at 8.4 . -100 ug of HRF was isolated from 100 mg of solubilized EH
membrane protein.A representative SDS-PAGE pattern ofHRF is shown in Fig .
1 . The M,. was 65,000 .
125I-labeled HRF in 0.02% DOC was added to a suspension of Es (4 X 107
cells/ml), which reduced the final DOC concentration to 0.004%. The cells were
kept at 37°C for 2h and washed thoroughly . In several such experiments, uptake
ofHRF by the cells varied between 1 and 4% . Fig . 2 shows the binding curve of
one ofthe studies in which 1,500-15,900 molecules per cell were bound in direct
proportion to input. The results of all uptake experiments indicate that the 65
kD HRF isolated from EH retained its membrane anchoring function .
HRF incorporated in the membrane of Es (Es-HRF) was tested for inhibition
of channel formation by C5b-9 using reactive lysis . The number of HRF mole-
cules on Es-HRF ranged from 530 to 8,500 per cell . Lysis of unmodified Es,
which had also been treated with 0.004% DOC, was 58%, and declined to 3%
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FIGURE 1 .
￿
Demonstration of HRF, isolated from human erythrocyte
membranes, by SDS-PAGE . The M, of the protein is 65 kD, and
comparison with the pattern of whole E membranes revealsno major
protein band corresponding to HRF. Amounts applied were 3 Ag of
HRF (center) and 40 Ag of membrane protein (right) . The gel concen-
trationwas 1.7-17% . The gel was stained with Coomassie blue. Molec-
ular mass standards are in the left lane.
FIGURE 2 .
￿
Uptake of 1251-HRF of hu-
man erythrocyte membranes by Es. 4 X
107 Es were treated with varying
amounts of 1251-HRF (0.16-1.58 rig),
which wascontained in 0.02% DOC for
2 h at 37°C . The total volume was 1 ml
and the final DOC concentration
0.004% .950
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at 8,500 HRF molecules per Es (Fig . 3) . The results indicate that HRF isolated
from EH also retained its function in inhibiting hemolysis by C5b-9 .
Inhibition ofADCC by HRFBound toESA or PNH-EA .
￿
Es-HRF bearing up to
3,200 molecules ofHRF per cell were sensitized with rabbit IgG anti-Esantibody
and subjected to ADCC using human LGL . The reaction mixtures were incu-
bated at 37°C for 4 h . In two experiments (Fig . 4) lysis of EsA devoid of human
HRF was 35 and 32%, respectively . In both cases, the incorporated HRF reduced
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FIGURE 3 .
￿
Inhibition ofreactive lysis with C5b-9
by isolated HRF bound to Es. 1251-HRF was incor-
porated into the membrane of Es , the number of
molecules per cell ranging from 530 to 8,500 . 10 7
Es-HRF were incubated for 2 h at 37°C with ^-3
jug C5b6, 2 ug C7, 2 kg C8, and 15 Wg C9 in a
volume of 50 ,I .
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FIGURE 4.
￿
Inhibition of ADCC by HRF bound to Es sensitized with IgG antibody . Samples
of 10 7 EsA bearing varyingamounts ofHRF were incubated for 4 h at 37 °C with 10 7 human
LGL in a total volume of 30 ul . Lysis was measured by determining hemoglobin in the
supernatant atOD412. The variation of lysis is indicated by the standard error bars (right), each
point representing three separate determinations . Also shown (right) is the lack of effect of
incorporated DAFon ADCC. Each point represents the average of twodeterminations.
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10lysis by ^-60% . Different preparations of HRF and different batches of Es were
used in these experiments. Detergent-treated EsA were used as HRF- controls
in all experiments. In a separate experiment, the effect of reinserted DAF on
ADCC was determined. Up to 3,300 molecules of 1251-DAF were bound per
EsA, and no effect on cellular cytotoxicity was observed (Fig. 4).
Abnormal PNH-E were enriched from the EH population of a patient with
PNH by lysis of the normal EH with rabbit anti-DAF and guinea pig complement.
After thorough washing, the unlysed DAF- (and HRF-) deficient cells were
sensitized with IgG rabbit anti-EH antibody and incubated for 4 h with a twofold
excess of human LGL . PNH-E without HRF underwent 20% lysis, and this
degree of lysis was completely abolished by 17,700 molecules of HRF per cell
(Fig. 5).
HRF Bound to Es Inhibits Hemolysis by Isolated C9RP.
￿
1251-HRF was incorpo-
rated into Es as described above, and 107 Es-HRF bearing 330 to 7,600 molecules
of HRF per cell were exposed to 5 wg of isolated C9RP in 20 A1 containing 5
mM Ca2+. Es treated with 0 .004% DOC in the absence of HRF were used as
control. After 5 h at 37°C, the controls had undergone 55 and 70% lysis,
whereas Es-HRF, with 4,250 or 7,600 molecules per cell, showed only 20 or
18% lysis (Fig. 6). Thus, HRF incorporation into Es resulted in 64-75% reduction
of Es lysis by C9RP.
Discussion
When HRF was first isolated in this laboratory from -70 ° C-stored EH mem-
branes, it was found to be a 38 kD protein (1). This protein was capable of
incorporating into the lipid bilayer of liposomes, and in this form was active in
inhibiting channel formation by C5b-8, C5b-9, and polymerizing C9 . Rabbit
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FIGURE 5.
￿
Inhibition of ADCC by HRFbound to the abnormal PNH-E. Theabnormal cells
were selectively enriched by removing the normal cells from the total E population. The cells
were sensitized with IgG antibody and were then incubated with varying amounts of ' 25I-HRF
for2 hat 37 °C. Afterwashing, theuptake of HRFwasdetermined and 107 treated cells were
then incubated with 2 X 107 LGL for 4 h at 37 °C in a total volume of 30 juI.952
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FIGURE 6. Inhibition of C9RP-induced
lysis of Es by cell bound HRF. In two sepa-
rate experiments, Eswere treated with var-
ious amountsof 'Y5I-HRF, washed,andthen
107 Es-HRF were exposed to 5 wg C9RP in
20 gl containing 5mM Ca"for5hat 37°C.
antibody to the 38 kD protein inhibited HRF activity on EH, human polymor-
phonuclear leukocytes, and Raji cells. The same antibody detected, in immuno-
blots offreshly isolated EH membrane, primarily a 65 kD protein. This observa-
tion suggested that the 38 kD protein was an active fragment of the 65 kD
membrane HRF. It also related HRF to the C8 binding protein described by
others (2).
Initially HRF was isolated from DOC-solubilized EH membranes by affinity
chromatography using human C9-Sepharose (1). Since then, more than 20 HRF
preparations have been obtained using rabbit anti-HRF immunoadsorbent col-
umns. In each instance, 65 kD HRF was isolated, including one preparation
derived from membranesofhuman LGL (our unpublished observation) . Because
abnormal PNH-Eexhibit enhanced sensitivity to reactive lysis by C5b-9 (15-18),
the membranes of such cells were investigated for HRF content and found
completely deficient in HRF (12). In that study, radioactive HRF was inserted
into PNH-E, and ^-1,000 molecules per cell were sufficient to confer normal
resistance to reactive lysis.
In this paper the present method of isolation of HRF is described, the 65 kD
HRF is demonstrated by SDS-PAGE, a binding curve describing the binding of
1251-HRF to Es is presented, and the acquisition ofresistance to lysis by C5b-9 is
shown as a function ofHRF uptake by Es.
Evidence has accumulated showing that killer lymphocytes use a discrete
protein ofMr ^-70,000 to produce aqueous pores in target membranes (3-6, 19,
20), and that this protein is immunochemically related to C9 (3-6, 21)and other
proteins of the membrane attack complex ofcomplement (7, 22). In view of the
similarities between the cytolytic C9RP of cytotoxic lymphocytes and C9, the
possibility was considered that HRF may inhibit channel formation, not only by
complement, but also by cytotoxic lymphocytes. Erythrocytes have been used
extensively as target cells in antibody-dependent cytolysis by lymphocytes (9, 23,ZALMAN ET AL.
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24). Since isolated human HRF may be readily incorporated into the membrane
of Es and EH, these cells were chosen as targets in the ADCC reaction with
human LGL. The results suggest that HRF is capable of inhibiting this reaction
in a dose-dependent manner, which is in contrast to DAF, insertion of which
into EsA had no effect on ADCC. They also imply that HRF can interact with
C9RP in a manner similar to its known interaction with C8 and C9. HRF binds
to both C8 (1, 2) and C9 (1) and it reduces uptake of C9 by EC5b-8 (1 and our
unpublished data). In the case of cytolysis by lymphocytes, HRF may interfere
with oligomerization and polymerization of C9RP. More work is clearly needed
to elucidate the molecular mechanism of action of HRF in the inhibition of
complement and lymphocyte cytotoxicity. To test the postulated interaction of
HRF with C9RP more directly, the effect ofmembrane-bound HRF on the lysis
of Es by isolated C9RP was examined. It should be emphasized that, unlike
murine perforin (20), human C9RP is a poor hemolytic agent. It is not clear why
erythrocytes are relatively resistant to lysis by C9RP whereasnucleated cells such
as K562 or M21 melanoma cells are readily killed (4, 6). Nevertheless, under the
conditions described, C9RP did cause lysis of Es, and the fact that this reaction
could be inhibited by Es-bound HRF suggests strongly that HRF and C9RP can
interact directly. The question arises, therefore, as to whether HRF may be
operative in self-protection ofcytotoxic lymphocytes.
Summary
The 65 kD homologous restriction factor (HRF) was isolated from normal
human erythrocytes (E) by immunoadsorption using rabbit anti-human HRF.
The protein was radiolabeled and incorporated into the membrane of sheep
erythrocytes (Es). Es bearing HRF exhibited a markedly reduced susceptibility
to reactive lysis by C5b-9. Es-HRF with 1,000-3,000 HRF molecules per cell
and sensitized with rabbit IgG anti-Es also were less susceptible to lysis by human
large granular lymphocytes (LGL) than untreated Es sensitized with IgG anti-
body. Similarly, human E ofa patientwith paroxysmal nocturnal hemoglobinuria
(PNH), lacking HRF and sensitized with IgGantibody underwent lysis by human
LGL. Lysis was abrogated by incorporation ofisolated human HRF. Incorpora-
tion of human decay-accelerating factor (DAF) into sensitized Es had no effect
on antibody-dependent, cell-mediated cytotoxicity. Furthermore, lysis of Es by
the isolated cytolytic C9-related protein (C9RP) ofhuman cytotoxic lymphocytes
could be inhibited by cell bound human HRF. These results suggest that HRF
inhibits channel formation not only by C5b-9, but also by cytotoxic lymphocytes.
Receivedfor publication 13 April 1987 and in revisedform 22June 1987.
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